» Articles » PMID: 21862725

Central Angiotensin II Has Catabolic Action at White and Brown Adipose Tissue

Overview
Date 2011 Aug 25
PMID 21862725
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Considerable evidence implicates the renin-angiotensin system (RAS) in the regulation of energy balance. To evaluate the role of the RAS in the central nervous system regulation of energy balance, we used osmotic minipumps to chronically administer angiotensin II (Ang II; icv; 0.7 ng/min for 24 days) to adult male Long-Evans rats, resulting in reduced food intake, body weight gain, and adiposity. The decrease in body weight and adiposity occurred relative to both ad libitum- and pair-fed controls, implying that reduced food intake in and of itself does not underlie all of these effects. Consistent with this, rats administered Ang II had increased whole body heat production and oxygen consumption. Additionally, chronic icv Ang II increased uncoupling protein-1 and β(3)-adrenergic receptor expression in brown adipose tissue and β3-adrenergic receptor expression in white adipose tissue, which is suggestive of enhanced sympathetic activation and thermogenesis. Chronic icv Ang II also increased hypothalamic agouti-related peptide and decreased hypothalamic proopiomelanocortin expression, consistent with a state of energy deficit. Moreover, chronic icv Ang II increased the anorectic corticotrophin- and thyroid-releasing hormones within the hypothalamus. These results suggest that Ang II acts in the brain to promote negative energy balance and that contributing mechanisms include an alteration in the hypothalamic circuits regulating energy balance, a decrease in food intake, an increase in energy expenditure, and an increase in sympathetic activation of brown and white adipose tissue.

Citing Articles

(Pro)renin receptor signaling in hypothalamic tyrosine hydroxylase neurons is required for obesity-associated glucose metabolic impairment.

Pan S, A C Souza L, Worker C, Reyes Mendez M, Gayban A, Cooper S JCI Insight. 2024; 9(6).

PMID: 38349753 PMC: 11063935. DOI: 10.1172/jci.insight.174294.


Early-life sodium deprivation programs long-term changes in ingestive behaviors and energy expenditure in C57BL/6J mice.

Ziegler A, Lawton S, Grobe C, Reho J, Freudinger B, Burnett C Am J Physiol Regul Integr Comp Physiol. 2023; 325(5):R576-R592.

PMID: 37720996 PMC: 10866575. DOI: 10.1152/ajpregu.00137.2023.


Pathophysiology of obesity and its associated diseases.

Jin X, Qiu T, Li L, Yu R, Chen X, Li C Acta Pharm Sin B. 2023; 13(6):2403-2424.

PMID: 37425065 PMC: 10326265. DOI: 10.1016/j.apsb.2023.01.012.


The hypothalamus as a key regulator of glucose homeostasis: emerging roles of the brain renin-angiotensin system.

Pan S, Worker C, Earley Y Am J Physiol Cell Physiol. 2023; 325(1):C141-C154.

PMID: 37273237 PMC: 10312332. DOI: 10.1152/ajpcell.00533.2022.


Melanocortin MCR receptor is required for energy expenditure but not blood pressure effects of angiotensin II within the mouse brain.

Oliveira V, Riedl R, Claflin K, Mathieu N, Ritter M, Balapattabi K Physiol Genomics. 2022; 54(6):196-205.

PMID: 35476598 PMC: 9131927. DOI: 10.1152/physiolgenomics.00015.2022.


References
1.
Weisinger R, Stanley T, Begg D, Weisinger H, Spark K, Jois M . Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet. Physiol Behav. 2009; 98(1-2):192-7. DOI: 10.1016/j.physbeh.2009.05.009. View

2.
Langhans W, Delprete E, Scharrer E . Mechanisms of vasopressin's anorectic effect. Physiol Behav. 1991; 49(1):169-76. DOI: 10.1016/0031-9384(91)90251-i. View

3.
Osborn J, Fink G . Region-specific changes in sympathetic nerve activity in angiotensin II-salt hypertension in the rat. Exp Physiol. 2009; 95(1):61-8. PMC: 2856071. DOI: 10.1113/expphysiol.2008.046326. View

4.
Eriksson L, Fyhrquist F . Plasma renin activity following central infusion of angiotensin II and altered CSF sodium concentration in the conscious goat. Acta Physiol Scand. 1976; 98(2):209-16. DOI: 10.1111/j.1748-1716.1976.tb00238.x. View

5.
Osborn J, Fink G, Kuroki M . Neural mechanisms of angiotensin II-salt hypertension: implications for therapies targeting neural control of the splanchnic circulation. Curr Hypertens Rep. 2011; 13(3):221-8. PMC: 3076522. DOI: 10.1007/s11906-011-0188-9. View